| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |